The primary purpose of this study is to evaluate the ability of oral triamcinalone given twice a day to patients with androgen independent prostate cancer to produce a sustained biochemical response. Secondary goals are to describe the safety and tolerability at this dose and schedule, to determine the time to sustained biochemical response, to determine the duration of biochemical response, to determine the time to disease progression.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
23
Stanford University Cancer Center
Stanford, California, United States
Ability of oral triamcinalone given twice a day to patients with androgen independent prostate cancer to produce a sustained biochemical response.
Time frame: Following treatment
Safety and tolerability at this dose and schedule, time to sustained biochemical response, duration of biochemical response, time to disease progression
Time frame: Following treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.